DYNAVAX TECHNOLOGIES CORPORATION
Biological E gets DGCA nod to begin the next phase of trials for its COVID-19 vaccineThis vaccine candidate includes an antigen that was in-licensed from BCM Ventures, which is an integrated commercialisation team of Baylor ...17 Nov, 2020, 08.16 AM IST
Load More